Objectives: The aim of this study was to understand the effect of rounding nodule size measurements on the frequency of positive results in the setting of lung cancer screening.
Introduction
Computed tomography (CT) screening for lung cancer has now been endorsed by major guideline organizations, including the U.S. Preventive Services Task Force, and has received approval for reimbursement by the Centers for Medicare and Medicaid Services.
1,2 These recommendations will undoubtedly lead to a marked increase in CT screening in the United States and worldwide as well. Among the many challenges to implementation of screening are minimizing potential harm and (perhaps the most challenging) management of small pulmonary nodules identified by the screenings.
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Concerns include the frequency of false positives and their attendant unnecessary work-up (including invasive procedures) and the potential for overtreatment, as well as the anxiety caused by both of these concerns.
Several approaches have been used to improve efficiency for the management of small pulmonary nodules, including raising the size thresholds to define positive results. Although this approach does not exclude the possibility that a small nodule is a cancer, the likelihood of these small nodules being cancer is extremely low. In addition, the likelihood of confirming growth at a malignant rate in less than 1 year before the next round of screening is extremely low. Therefore, on the basis of retrospective analysis of large studies, current guidelines recommend a repeat CT scan in 1 year's time for pulmonary nodules less than a specified size threshold, and for nodules larger than this threshold, a follow-up scan at either 3 or 6 months to assess nodule growth is commonly recommended. [3] [4] [5] [6] The American College of Radiology has developed a standardized lung nodule classification and reporting system (Lung CT Screening Reporting and Data System [Lung-RADS]) for the management of nodules on the basis of various nodule features, including consistency, size, and the round of screening. 4 Measurement of nodule size is particularly important, as it determines whether the nodule is below or above the threshold for further work-up, thus defining the value for a positive result. Change in nodule size to a sufficient extent (growth) also defines a positive result and prompts additional evaluation. In the initial version of Lung-RADS, (version 1.0), the following guidance is provided: "nodules should be measured on lung windows and reported as the average diameter rounded to the nearest whole number; for round nodules only a single diameter measurement is necessary." In regard to growth, the criterion of an increase in size of more than 1.5 mm is used. For example, in the baseline round using Lung-RADS Version 1.0, an average nodule diameter of 5.5 mm is reported as 6 mm, and because 6 mm is the current threshold for a positive result, further work-up would be recommended for this nodule. Similarly, an average diameter of 2.5 mm would be reported as 3 mm on annual rounds, and on the basis of the International Early Lung Cancer Action Program (I-ELCAP) protocol, further work-up would also be recommended. In Lung-RADS, 3.5 mm would be reported as 4 mm on annual rounds and additional work-up would also be recommended. Rounding to the nearest whole number thus increases the frequency of positive results requiring further work-up before the next round of screening as compared with protocols that maintain the decimal point, which would allow for a nodule with a diameter of 5.5 mm on baseline (or 2.5 mm for I-ELCAP and 3.5 mm for Lung-RADS on annual rounds) to remain below the threshold value.
It should be recognized that the frequency of positive results is determined not only by whether the decimal place is maintained but also by when the rounding occurs, either on individual measures of length and width or, alternatively, afterward, when the length and width are averaged. This is not specified in Lung-RADS Version 1.0.
We wanted to explore how the definitions used in Lung-RADS Version 1.0 for size measurement and growth determination would influence the frequency of positive results, as this should provide insight for further refinements in the planned updates.
Materials and Methods
We evaluated four different methods for calculating the nodule diameter on the basis of measurements of the length and width as follows: (1) measuring length and width to one decimal place and calculating the diameter without rounding, (2) rounding the calculated average diameter to the nearest integer, (3) rounding the length and width measurements to the nearest integer before calculating the average diameter with no further rounding, and (4) rounding the calculated average diameter determined by method 3 to the nearest integer.
Under an institutional review board-approved and Health Insurance Portability and Accountability Actcompliant protocol, we evaluated the same I-ELCAP database on 21,136 participants, which led to establishment of the 6.0-mm size threshold for the definition of a positive result requiring further work-up in the baseline round of screening to determine the effect of each rounding method. 5 This data set is particularly useful to understand the consequences of rounding, as the length and width measurements were recorded to one decimal place and the diameter was calculated without rounding. No specific instructions were given in terms of whether to use magnification when performing the measurements. When the 6.0-mm size threshold was used, the frequency of positive results was 10.2%. 5 This I-ELCAP result had been further validated by using the National Lung Screening Trial (NLST), but in this database the length and width recorded were already rounded to a whole number. 6 The NLST data would allow us to determine only the impact of methods 3 and 4 and not that of methods 1 and 2; thus, we limited the analysis to the I-ELCAP cohort.
To understand the impact of rounding on growth assessment, we calculated the minimum volume doubling time required for a nodule of a given size to meet the required criterion of 1.5 mm of growth within the recommended follow-up period. To calculate volume doubling times, length and width were used as inputs to the modified Schwartz equation to calculate nodule volume doubling times by using a simple exponential model with the time between scans chosen according to the Lung-RADS recommendation. 4, 7, 8 Results
Frequency of a Positive Result
Among the 21,136 subjects in I-ELCAP, the frequency of positive results in the baseline round was 10.2% (2159 of 21,136) when a threshold value of 6.0 mm was used without rounding as in method 1 (Table 1) . When method 2 was used and the average diameter was rounded to the nearest integer without rounding the length and width measurements to the nearest integer, the frequency of positive results increased to 12.8% (2714 of 21,136). If the length and width measurements were both rounded to the nearest whole number before determining the average diameter, which was not rounded to the nearest integer (method 3), the frequency of positive results was 10.5% (2223 of 21,136). However, if the average diameter was rounded to the nearest whole number after rounding length and width to the nearest integer (method 4), the frequency increased to 13.2% (2784 of 21,136) (Fig. 1) .
When rounding at different points was used in deter- Among the 2159 participants with positive results on baseline CT in the I-ELCAP database, the size of the largest nodule was between 6 and 9 mm in 1476 (68.4%), between 10 and 14 mm in 398 (18.4%), and 15 mm or larger in 285 (13.2%). Because most of the nodules were in the 6-to 9-mm range, rounding to the nearest integer had the most impact for this size category. Compared with method 1, according to which there were 1476 participants (7.0%) whose largest nodule was between 6 and 9 mm, the number of participants with their largest nodule between 6 and 9 mm increased to 1961 (9.3%) with method 2, to 1533 (7.3%) with method 3, and to 2017 (9.5%) with method 4. The increase when methods 2, 3, and 4 were used increased the frequency of 6-to 9-mm nodules by 32.9%, 3.9%, and 36.7%, respectively (Fig. 2) 
A total of 85,877 annual repeat screenings were performed in the I-ELCAP database. When method 1 was used, the frequency of positive result was 8.0% (6891 of 85,877) when the size threshold was 3 mm (Table 2) . When methods 2, 3 and 4 were used, the frequency of positive results increased to 9.7% (8306 of 85,877), 8.3% (7109 of 85,877), and 9.8% (8428 of 85,877), respectively. Thus, for annual repeat rounds, when compared with the results obtained by method 1, the percentage of positive results increased by 20.5% when method 2 was used, by 3.2% when method 3 was used, and by 22.3% when method 4 was used (see Fig. 1 ). Again, the results obtained with method 1 and those obtained with method 2 were significantly different (p < 0.0001), as were the results obtained by method 1 versus by method 4 (p < 0.0001); however, whereas the results obtained by method 1 and by method 3 were not (p ¼ 0.05).
Among the 6891 CT scans with positive findings in 85,877 annual repeat screenings in the I-ELCAP cohort, the size of the largest nodule was 3 to 6 mm in 4998 of the participants (72.5%), 6 to 9 mm in 1199 (17.4%), 10 to 14 mm in 409 (5.9%), and 15 mm or larger in 285 (4.1%). Because most of the nodules were in the less than 10-mm size range, rounding had the most impact on these size categories. Compared with method 1, which resulted in 5.8% of nodules (4998 of 85,877) with 
Growth Assessment
For nodules ranging in size from 3.0 to 10.0 mm (average diameter), we plotted the minimum volume doubling times required for the nodule to grow by 1.5 mm within the time frame specified by Lung-RADS Version 1.0 (Fig. 4) . For example, in Lung-RADs category 3, a 6-month follow-up CT is recommended for a new 4-mm solid nodule (with rounding, such a nodule ranges from 3.5 to 4.4 mm in average diameter). To document growth, the nodule must grow to at least 5.5 mm within that time and therefore must have a volume doubling time ranging from 92.0 to 186.4 days or less (depending on the initial rather than rounded size) to reach this size. If the volume doubling time is slower, nodule growth would not be sufficient to reach this threshold and the next scan would therefore occur 6 months later. Assuming that the nodule continued to grow at that same rate, it would be 8.6 to 10.7 mm in diameter at the follow-up 6 months later. Similarly, for Lung-RADS category 4A, a new 6-mm solid nodule (with rounding, such a nodule ranges from 5.5-6.4 mm) would have to grow to be at least 7.5 mm within 3 months. This would require a volume doubling time ranging from 67.0 to 131.1 days or less; otherwise, a repeat scan would be performed 9 months later, when the nodule could potentially have reached a size of 10.2 to 11.9 mm.
Discussion
The efficiency gained by raising the nodule threshold for definition of a positive result has been demonstrated in several studies, including ones based on the I-ELCAP and NLST databases. 5, 6 These studies, among others, were considered in the development of the Lung-RADS Version 1. 4 The need to improve efficiency is prompted by the concerns about the potential harm of unnecessary workups. For this reason, Lung-RADS Version 1 adopted a 6 mm size threshold for positive result on a baseline round and 4 mm on a repeat round (for I-ELCAP it is 3.0 mm), which requires rounding to the nearest millimeter. As we showed, however, rounding results in a higher frequency of positive results. We found that regardless of where the rounding occurs (whether on the individual length or width measurements, or the average), the effect of rounding on baseline (a threshold of 6 mm is used for a positive result), the frequency of positive result was increased. The largest increase, 28.9% (from 10.2% to 13.2%), occurred with method 4, where length and width were rounded and the average diameter of these two measurements was also rounded. On annual repeat rounds (a cutoff of 3 mm is used for a positive result in the I-ELCAP), method 4 also showed the greatest increase (22.3% [from 8.0 to 9.8%]).
In both the baseline and annual repeat rounds, method 1, method 2, and method 4 were significantly different from each other, whereas method 1 and method 3 were not significantly different from one another.
The I-ELCAP article demonstrated a balance between the frequencies of positive results and the number of cancers that would have a delayed diagnosis. 5 Similar results were also demonstrated when the NLST database was used. 6 In Lung-RADS Version 1, the threshold of 6 mm (no decimal point) was used at baseline, which meant that nodules 5.5 mm or larger were considered a positive result. Given that nodules are more abundant in When the decimal point in the aforementioned example was eliminated, the result was changed from two significant digits to one significant digit, which caused an increase in positive results. Although this is an undesired consequence, it is reflective of the recognition that there is substantial uncertainty in measuring size in the submillimeter range, especially when electronic calipers are used, even though they typically provide measurements to the tenth of a millimeter. Also, from a statistical viewpoint, it is generally accepted that when rounding is performed to determine a mean value, the individual measures should not be rounded and rounding should occur only in the final step. 9 In addition to resulting in a higher frequency of positive results, rounding also affects assessment of growth. If a 6.6-mm nodule increases to 8.1 mm on the follow-up scan, it will meet the criterion of 1.5 mm required for growth. However, if average diameter is being rounded to the nearest whole number on both the scans, the nodule will be reported as a 7-mm nodule that increases to 8 mm and therefore does not meet the required criterion. In another scenario, a 6.4-mm nodule that increases to 7.5 mm on the follow-up scan and thus does not meet the 1.5-mm required growth criterion would be reported as a 6-mm nodule that had increased to 8 mm if the average diameters had been rounded to the nearest whole number, it would thus meet the criterion. These examples demonstrate that rounding can lead to nodules being categorized as not growing when they actually do meet the criterion for growth, and also as growing when they do not meet the growth criterion. We also demonstrated that the 1.5-mm growth criterion requires rapid volume doubling times of nodules. For a new nodule with average diameter of 4 mm, the volume doubling times would need to be 130.6 days to demonstrate growth in 6 months (Lung-RADS category 3), and for a 6-mm nodule it would need to be 93.2 days in 3 months (Lung-RADS category 4A). Typical volume doubling times for cancers found in annual repeat screening rounds have a median value of approximately 100 days. 10 This implies that using the 1.5-mm criterion for growth would mean that approximately half of those screening participants with cancers in those categories would have to wait an additional 6 to 9 months for their cancer to be diagnosed on their next annual repeat round, at which time the cancer would be considerably larger. When the effect that rounding has on overall diameter values is considered, the required volume doubling times may be even shorter. For example, a nodule that measures 2.5 Â 3.5 mm would have a diameter of 3.0 mm, but with rounding, this would become 3 Â 4 mm with an average diameter of 4 mm. So instead of needing a volume doubling time of 130.6 days to reach the threshold required to establish growth in 6 months, it would need a volume doubling time of 68.6 days. Similarly, a 5.0-mm nodule could potentially be rounded to 6 mm (a 4.5 Â 5.5-mm nodule would have a diameter of 5.0 mm, but with rounding, it would become 5 Â 6 mm with an average of 6 mm), which would mean that instead of a doubling time of 93.2 days for growth to be seen in 3 months, volume doubling time would have to be even shorter (51.3 days).
Limitations of this study include the challenges associated with using current techniques when measuring length and width with precision in the submillimeter range. However, this limitation needs to be balanced by consideration of the consequences of increased false positives and rapid doubling time necessary for growth documentation. A second limitation is the use of a single database to measure the effect on positive rates. However, the I-ELCAP database is a large multicenter cohort that was originally used to set the standard for moving the size threshold to 6.0 mm, which was subsequently validated using the NLST database.
Although it is clear that any of the choices we make in terms of measuring a nodule remain a compromise, the limitations associated with rounding to the nearest millimeter present substantial challenges to screening efficiency by increasing the frequency of positive results, as well as by requiring very rapid doubling times to demonstrate growth. Ultimately, with the increasing resolution of CT scanners, the rationale for rounding should further diminish. Also, as the field continues to move toward computer-assisted techniques to measure volumes, the issue of rounding is essentially disappearing, as techniques already exist to measure more precisely in the submillimeter range by using various forms of interpolation. Groups such as the Radiological Society of North America Quantitative Imaging Biomarkers Alliance are now helping to set standards for these types of measurements.
